Big Formulation Breakthroughs
Add bookmark
Big Formulation Breakthroughs
Add bookmark
David Elder, Externalisation Director for GlaxoSmithKline and Pharma IQ Advisory Board Member, joins Andrea Charles from Pharma IQ, to discuss the most critical unmet drug delivery need and the benefits of early formulation testing. Elder shares his insights on how he thinks formulation screening and testing will develop in the next five years and what will be the next big thing in the field.
[inlinead]
Tags:
David Elder
GSK
Formulation
drug delivery
early formulation
preformulation
formulation screening
formulation testing
